Safety Study of DNA Vaccine Delivered by Intradermal Electroporation to Treat Colorectal Cancer

NCT01064375 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

16

Enrollment

OTHER

Sponsor class

Conditions

Colorectal Cancer

Interventions

BIOLOGICAL: tetwtCEA DNA (wt CEA with tetanus toxoid Th epitope)
DEVICE: Derma Vax (electroporation device)
BIOLOGICAL: GM-CSF
DRUG: Cyclophosphamide

Sponsor

Maria Liljefors

Collaborators

[object Object]
[object Object]
[object Object]